Healthcare Reform
Featured Topics
Lead story
Other featured articles
-
Drug Rebates in Medicare Part D
On July 27, the USC-Brookings Schaeffer Initiative for Health Policy will host a webinar to discuss how the increasing reliance on rebates burdens many Medicare patients and policy solutions.
Posted in -
Comparison of Spending on Common Generic Drugs by Medicare vs Costco Members
A new Schaeffer Center study comparing Medicare Part D prescription drug prices with those paid by Costco members finds that the federal government overpaid on roughly half of the most common generic medicines in 2018.
Posted in -
USC Research Shows Costco Beats Medicare in Generic Drug Savings Nearly 50% of the Time
Intermediaries negotiate good prices, but lack incentives to pass savings to beneficiaries and taxpayers.
Posted in -
A Medical Moonshot Would Help Fix Inequality in American Healthcare
New medical interventions can serve as a great leveler and help change the trajectory of health disparities in the United States.
Posted in
About this section
Healthcare reform should hinge on improving value, reducing waste, and bettering the health outcomes of patients. The Schaeffer Center is a pioneer in posing solutions to enhance the value of healthcare services and expand their reach.
Our Experts On Healthcare Reform
Our Work In Healthcare Reform
-
Experts at Schaeffer-Aspen Webinar Discuss Modernizing Health Technology Assessment in the U.S.
The U.S. does not have a coordinated process to evaluate the effectiveness and value of new devices, medicines or procedures. Schaeffer Center and the Aspen Institute hosted a panel discussion on the viability of an Institute of Health Technology Assessment.
-
Precision Medicine: Moving Theory into Practice
Over a four-part webinar series, Schaeffer Center will bring together experts to discuss how we can move precision medicine from theory to practice.
-
Developing Effective Payment and Reimbursement Models
Targeted therapies can come with significant costs. But successful use of personalized medicine can also result in better healthcare outcomes and reduced long-term costs over time. Given this, how we pay for these therapies may require new approaches and models.
-
Using Precision Medicine in Clinical Practice
Despite its promise and multimillion dollar federal investments, the development and implementation of precision medicine in routine clinical care continues to be slow. How can we translate theory into practice?
-
Can Health Technology Assessment Control Spending and Reward Innovation?
Could an Institute of Health Technology Assessment facilitate more rational decisions on healthcare that reward both innovation and quality across the entire spectrum of care?
-
The Case for Replacing “Silver Loading”
An analysis of how a public option may or may not reduce healthcare costs in the U.S.